Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
Pharmacotherapy
|
July 19, 2013
Epigenetics primer: why the clinician should care about epigenetics
Julio D Duarte
Nature Reviews. Cardiology
|
May 6, 2021
Pharmacogenetics to guide cardiovascular drug therapy
Julio D Duarte, Larisa H Cavallari
Journal of Clinical Pharmacology
|
November 12, 2014
Genes affecting warfarin response-interactive or additive?
Larisa H Cavallari, Julio D Duarte
Journal of the American Heart Association
|
May 25, 2021
Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease
Christelle Lteif, Ali Ataya, Julio D Duarte
Frontiers in Genetics
|
June 4, 2025
Lack of association between genetic variations in <i>CYP3A5</i> and blood pressure or hypertension risk in the UK biobank
Pia Leibold, Christelle Lteif, Julio D Duarte
Expert Review of Cardiovascular Therapy
|
June 10, 2010
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics
Julio D Duarte, Rhonda M Cooper-DeHoff
Clinical and Translational Science
|
May 6, 2021
Patients with geographic barriers to health care access are prescribed a higher proportion of drugs with pharmacogenetic testing guidelines
Rachel Dalton, Joshua D Brown, Julio D Duarte
Current Hypertension Reports
|
August 15, 2015
Pharmacogenomics of hypertension and heart disease
Meghan J Arwood, Larisa H Cavallari, Julio D Duarte
Frontiers in Pharmacology
|
April 10, 2024
Estimating preferences and willingness to pay for pharmacogenetic testing in populations who are medically underserved: a discrete choice experiment
Brian E Gawronski, Ramzi G Salloum, Julio D Duarte
Future Cardiology
|
May 15, 2013
Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics
Julio D Duarte, Rebekah L Hanson, Roberto F Machado
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
Pharmacotherapy
|
July 19, 2013
Epigenetics primer: why the clinician should care about epigenetics
Julio D Duarte
Nature Reviews. Cardiology
|
May 6, 2021
Pharmacogenetics to guide cardiovascular drug therapy
Julio D Duarte, Larisa H Cavallari
Journal of Clinical Pharmacology
|
November 12, 2014
Genes affecting warfarin response-interactive or additive?
Larisa H Cavallari, Julio D Duarte
Journal of the American Heart Association
|
May 25, 2021
Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease
Christelle Lteif, Ali Ataya, Julio D Duarte
Frontiers in Genetics
|
June 4, 2025
Lack of association between genetic variations in <i>CYP3A5</i> and blood pressure or hypertension risk in the UK biobank
Pia Leibold, Christelle Lteif, Julio D Duarte
Expert Review of Cardiovascular Therapy
|
June 10, 2010
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics
Julio D Duarte, Rhonda M Cooper-DeHoff
Clinical and Translational Science
|
May 6, 2021
Patients with geographic barriers to health care access are prescribed a higher proportion of drugs with pharmacogenetic testing guidelines
Rachel Dalton, Joshua D Brown, Julio D Duarte
Current Hypertension Reports
|
August 15, 2015
Pharmacogenomics of hypertension and heart disease
Meghan J Arwood, Larisa H Cavallari, Julio D Duarte
Frontiers in Pharmacology
|
April 10, 2024
Estimating preferences and willingness to pay for pharmacogenetic testing in populations who are medically underserved: a discrete choice experiment
Brian E Gawronski, Ramzi G Salloum, Julio D Duarte
Future Cardiology
|
May 15, 2013
Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics
Julio D Duarte, Rebekah L Hanson, Roberto F Machado
Page
of 8